Back to Search Start Over

Differential expression and signaling of the human histamine H 3 receptor isoforms of 445 and 365 amino acids expressed in human neuroblastoma SH-SY5Y cells.

Authors :
Nieto-Alamilla G
Escamilla-Sánchez J
López-Méndez MC
Molina-Hernández A
Guerrero-Hernández A
Arias-Montaño JA
Source :
Journal of receptor and signal transduction research [J Recept Signal Transduct Res] 2018 Apr; Vol. 38 (2), pp. 141-150. Date of Electronic Publication: 2018 Mar 20.
Publication Year :
2018

Abstract

In stably-transfected human neuroblastoma SH-SY5Y cells, we have compared the effect of activating two isoforms of 445 and 365 amino acids of the human histamine H <subscript>3</subscript> receptor (hH <subscript>3</subscript> R <subscript>445</subscript> and hH <subscript>3</subscript> R <subscript>365</subscript> ) on [ <superscript>35</superscript> S]-GTPγS binding, forskolin-induced cAMP formation, depolarization-induced increase in the intracellular concentration of Ca <superscript>2+</superscript> ions ([Ca <superscript>2+</superscript> ]i) and depolarization-evoked [ <superscript>3 </superscript> H]-dopamine release. Maximal specific binding (B <subscript>max</subscript> ) of [ <superscript>3 </superscript> H]-N-methyl-histamine to cell membranes was 953 ± 204 and 555 ± 140 fmol/mg protein for SH-SY5Y-hH <subscript>3</subscript> R <subscript>445</subscript> and SH-SY5Y-hH <subscript>3</subscript> R <subscript>365</subscript> cells, respectively, with similar dissociation constants (K <subscript>d</subscript> , 0.86 nM and 0.81 nM). The mRNA of the hH <subscript>3</subscript> R <subscript>365</subscript> isoform was 40.9 ± 7.9% of the hH <subscript>3</subscript> R <subscript>445</subscript> isoform. No differences in receptor affinity were found for the H <subscript>3</subscript> R ligands histamine, immepip, (R)(-)-α-methylhistamine (RAMH), A-331440, clobenpropit and ciproxifan. Both the stimulation of [ <superscript>35</superscript> S]-GTPγS binding and the inhibition of forskolin-stimulated cAMP accumulation by the agonist RAMH were significantly larger in SH-SY5Y-hH <subscript>3</subscript> R <subscript>445</subscript> cells ([ <superscript>35</superscript> S]-GTPγS binding, 158.1 ± 7.5% versus 136.5 ± 3.6% for SH-SY5Y-hH <subscript>3</subscript> R <subscript>365</subscript> cells; cAMP accumulation, -74.0 ± 4.9% versus -43.5 ± 5.3%), with no significant effect on agonist potency. In contrast, there were no differences in the efficacy and potency of RAMH to inhibit [ <superscript>3 </superscript> H]-dopamine release evoked by 100 mM K <superscript>+</superscript> (-18.9 ± 3.0% and -20.5 ± 3.3%, for SH-SY5Y-hH <subscript>3</subscript> R <subscript>445</subscript> and SH-SY5Y-hH <subscript>3</subscript> R <subscript>365</subscript> cells), or the inhibition of depolarization-induced increase in [Ca <superscript>2+</superscript> ]i (S2/S1 ratios: parental cells 0.967 ± 0.069, SH-SY5Y-hH <subscript>3</subscript> R <subscript>445</subscript> cells 0.639 ± 0.049, SH-SY5Y-hH <subscript>3</subscript> R <subscript>365</subscript> cells 0.737 ± 0.045). These results indicate that in SH-SY5Y cells, hH <subscript>3</subscript> R <subscript>445</subscript> and hH <subscript>3</subscript> R <subscript>365</subscript> isoforms regulate in a differential manner the signaling pathways triggered by receptor activation.

Details

Language :
English
ISSN :
1532-4281
Volume :
38
Issue :
2
Database :
MEDLINE
Journal :
Journal of receptor and signal transduction research
Publication Type :
Academic Journal
Accession number :
29557708
Full Text :
https://doi.org/10.1080/10799893.2018.1448995